Physician profile
Vance A Broach
NPI 1063649085
$4,108.36
in general payments reported to CMS, 2019-2025
9 companies · $2,882 in 2025
The $2,882 reported for 2025 was more than what 82% of Gynecologic Oncology providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $352 · 2020: $280 · 2022: $169 · 2023: $405 · 2024: $21.00 · 2025: $2,882.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,823 · Travel and Lodging: $1,485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,822.67 |
| Travel and Lodging | $1,485.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,802.35 | 2025 | |
| Medtronic, INC. | $1,235.65 | 2022-2025 | Truclear |
| Astrazeneca Pharmaceuticals LP | $249.12 | 2019-2023 | Lynparza |
| Davol INC. | $189.26 | 2025 | Arista |
| Edwards Lifesciences Corporation | $151.11 | 2020 | |
| Biom'Up France Sas | $128.95 | 2020 | |
| Coopersurgical, INC. | $125.00 | 2023 | Advincula Delineator Uterine Manipulator |
| Kci USA, INC. | $114.57 | 2019 | |
| Ethicon US, LLC | $112.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vance Broach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.